A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men
Open Access
- 1 December 2015
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 2 (12) , 1957-1964
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- Breast Cancer Research Foundation
- H. L. Snyder Medical Foundation (KMR-12-1-2012-0216, OTKA-114560)
- Novo Nordisk Fonden (KTIA_NAP_13-2014-0021, MTA-TKI643/2012)
This publication has 56 references indexed in Scilit:
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerNature Genetics, 2012
- The mutational landscape of lethal castration-resistant prostate cancerNature, 2012
- The genomic complexity of primary human prostate cancerNature, 2011
- Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancerThe Prostate, 2010
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratificationProstate Cancer and Prostatic Diseases, 2010
- BreakDancer: an algorithm for high-resolution mapping of genomic structural variationNature Methods, 2009
- LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridizationGenes, Chromosomes and Cancer, 2009
- Principal components analysis corrects for stratification in genome-wide association studiesNature Genetics, 2006